Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GPT HealthcareNSE:GPTHEALTH -3.39%43 5-Year Yield-on-Cost % is 1.52 as of Aug. 09, 2026, which is 7% below its 10-year median of 1.64. GuruFocus rates NSE:GPTHEALTH with a GF Score™ of 43/100. The stock has 3 warning signs investors should review. Among 275 Healthcare Providers & Services companies, GPT Healthcare ranks worse than 70.91% on this metric.
GPT Healthcare's yield on cost for the quarter that ended in Mar. 2026 was 1.52.
The historical rank and industry rank for GPT Healthcare's 5-Year Yield-on-Cost % or its related term are showing as below:
NSE:GPTHEALTH'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.52 Med: 1.64 Max: 2.67
Current: 1.52
During the past 6 years, GPT Healthcare's highest Yield on Cost was 2.67. The lowest was 0.52. And the median was 1.64.
NSE:GPTHEALTH's 5-Year Yield-on-Cost % is ranked worse than 70.91% of 275
companies
in the Healthcare Providers & Services industry
Industry Median: 2.9
vs NSE:GPTHEALTH: 1.52
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
GPT Healthcare 5-Year Yield-on-Cost % Related Terms
NSE:GPTHEALTH vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, GPT Healthcare's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GPT Healthcare 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GPT Healthcare's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where GPT Healthcare's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of GPT Healthcare is calculated as
GPT Healthcare (NSE:GPTHEALTH) has a 5-Year Yield-on-Cost % of 1.52 as of Aug. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on GPT Healthcare and its competitors. This is near median its historical median of 1.64. Over the past decade, GPT Healthcare's 5-Year Yield-on-Cost % has ranged from 0.52 to 2.67. According to the industry distribution chart, GPT Healthcare ranks #195 out of 275 companies in the Healthcare Providers & Services industry, placing it in the top 70.9%.
Is GPT Healthcare's 5-Year Yield-on-Cost % too high?
GPT Healthcare's current 5-Year Yield-on-Cost % of 1.52 is near median its 10-year median of 1.64. Over the past 10 years, this metric has ranged from a low of 0.52 to a high of 2.67. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.90. GPT Healthcare's value of 1.52 is 47.6% below this industry median. Based on the distribution chart, GPT Healthcare ranks #195 out of 275 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, GPT Healthcare has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does GPT Healthcare's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, GPT Healthcare ranks #195 out of 275 companies for 5-Year Yield-on-Cost %. This places GPT Healthcare in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.90. GPT Healthcare's value of 1.52 is 47.6% below this benchmark. Historically, GPT Healthcare's own 5-Year Yield-on-Cost % has ranged from 0.52 to 2.67 over the past decade. While the company's 10-year median is 1.64 vs. the industry median of 2.90, GPT Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.90, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GPT Healthcare's current 5-Year Yield-on-Cost % of 1.52 is 47.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on GPT Healthcare and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GPT Healthcare's current 5-Year Yield-on-Cost % is 1.52, which is near median its own 10-year median of 1.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPT Healthcare stock overvalued right now?
GPT Healthcare (NSE:GPTHEALTH) has a current 5-Year Yield-on-Cost % of 1.52. The current 5-Year Yield-on-Cost % is 1.52, which is near median its 10-year median of 1.64 and 47.6% below the Healthcare Providers & Services industry median of 2.90. GPT Healthcare's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For GPT Healthcare (NSE:GPTHEALTH), the current 5-Year Yield-on-Cost % is 1.52 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GPT Healthcare Ltd is engaged in the healthcare sector. It operates a chain of mid-sized full-service hospitals under the ILS brand. It provides integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of approximately 561 beds. It offers a comprehensive range of healthcare services across over 35 specialities and super specialities, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.
43GF Score
Get the complete analysis for NSE:GPTHEALTH
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GPTHEALTH has been successfully added to your 
